ZA200201708B - Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system. - Google Patents

Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system.

Info

Publication number
ZA200201708B
ZA200201708B ZA200201708A ZA200201708A ZA200201708B ZA 200201708 B ZA200201708 B ZA 200201708B ZA 200201708 A ZA200201708 A ZA 200201708A ZA 200201708 A ZA200201708 A ZA 200201708A ZA 200201708 B ZA200201708 B ZA 200201708B
Authority
ZA
South Africa
Prior art keywords
water
administration
distribution system
target animal
insoluble drug
Prior art date
Application number
ZA200201708A
Other languages
English (en)
Inventor
Peter Frank Ekhart
Jan Matthijs Jetten
Mario Van Wandelen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA200201708B publication Critical patent/ZA200201708B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200201708A 1999-09-03 2002-02-28 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system. ZA200201708B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99202876 1999-09-03

Publications (1)

Publication Number Publication Date
ZA200201708B true ZA200201708B (en) 2003-08-27

Family

ID=8240608

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200201708A ZA200201708B (en) 1999-09-03 2002-02-28 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system.

Country Status (35)

Country Link
US (1) US9040571B2 (sh)
EP (1) EP1214052B1 (sh)
JP (1) JP4754139B2 (sh)
KR (1) KR100702540B1 (sh)
CN (1) CN1165289C (sh)
AR (1) AR025470A1 (sh)
AT (1) ATE273000T1 (sh)
AU (1) AU775216B2 (sh)
BG (1) BG65673B1 (sh)
BR (1) BR0013754A (sh)
CA (1) CA2383164C (sh)
CZ (1) CZ301938B6 (sh)
DE (1) DE60012947T2 (sh)
EA (1) EA004785B1 (sh)
EE (1) EE05052B1 (sh)
ES (1) ES2226914T3 (sh)
HK (1) HK1049628B (sh)
HR (1) HRP20020173B1 (sh)
HU (1) HU229311B1 (sh)
IL (2) IL148438A0 (sh)
MA (1) MA25432A1 (sh)
ME (1) ME00132B (sh)
MX (1) MXPA02002360A (sh)
MY (1) MY128072A (sh)
NZ (1) NZ517024A (sh)
PL (1) PL201484B1 (sh)
PT (1) PT1214052E (sh)
RS (1) RS50341B (sh)
SI (1) SI1214052T1 (sh)
SK (1) SK285825B6 (sh)
TR (1) TR200200532T2 (sh)
TW (1) TWI234468B (sh)
UA (1) UA72933C2 (sh)
WO (1) WO2001017504A1 (sh)
ZA (1) ZA200201708B (sh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1379242B1 (en) * 2001-03-26 2012-08-15 Newsouth Innovations Pty Limited Method for treatment of cancer and compositions for use therein
ATE467637T1 (de) 2005-07-28 2010-05-15 Intervet Int Bv Neue benzimidazol(thio)carbamate mit antiparasitischer wirkung und ihre synthese
KR101403135B1 (ko) 2006-06-14 2014-06-19 인터벳 인터내셔널 비.브이. 벤지미다졸 카르바메이트 및 폴리솔베이트를 포함하는 현탁물
AR077320A1 (es) 2009-07-20 2011-08-17 Intervet Int Bv Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden.
EP2409683A1 (en) 2010-07-06 2012-01-25 KRKA, D.D., Novo Mesto Stable aqueous formulations comprising poorly water soluble active ingredients
RU2522267C2 (ru) * 2012-08-28 2014-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции фенбендазола
RU2522229C1 (ru) * 2013-03-26 2014-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Юго-Западный государственный университет" (ЮЗ ГУ) Способ инкапсуляции фенбендазола
RU2545742C2 (ru) * 2013-07-23 2015-04-10 Александр Александрович Кролевец Способ инкапсуляции лактобифадола
RU2555782C1 (ru) * 2014-03-03 2015-07-10 Александр Александрович Кролевец Способ получения нанокапсул сульфата глюкозамина в конжаковой камеди в гексане
RU2555055C1 (ru) * 2014-03-18 2015-07-10 Александр Александрович Кролевец Способ получения нанокапсул сульфата глюкозамина в ксантановой камеди
RU2558084C1 (ru) * 2014-03-18 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул аспирина в каррагинане
RU2557941C1 (ru) * 2014-03-20 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул аспирина в альгинате натрия
RU2554759C1 (ru) * 2014-04-07 2015-06-27 Александр Александрович Кролевец Способ получения нанокапсул лозартана калия
ES2925656T3 (es) * 2016-04-29 2022-10-19 Rousselot B V Excipiente basado en proteínas para principios farmacéuticos activos
CN110151692A (zh) * 2019-06-21 2019-08-23 石家庄九鼎动物药业有限公司 一种兽用抗寄生虫药物阿苯达唑混悬液制备方法
CN110693830B (zh) * 2019-10-10 2021-09-17 华中农业大学 一种兽用奥芬达唑纳米混悬液及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2336931A1 (fr) * 1975-12-30 1977-07-29 Dick Pierre Compositions anthelminthiques a base de benzimidazoles
US5538989A (en) * 1993-11-10 1996-07-23 Hoechst-Roussel Agri-Vet Company Fenbendazole formulations
NZ260018A (en) * 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions

Also Published As

Publication number Publication date
HRP20020173A2 (en) 2004-04-30
CN1372462A (zh) 2002-10-02
MA25432A1 (fr) 2002-04-01
NZ517024A (en) 2003-05-30
EA200200325A1 (ru) 2002-08-29
CN1165289C (zh) 2004-09-08
DE60012947D1 (de) 2004-09-16
CZ301938B6 (cs) 2010-08-04
EP1214052A1 (en) 2002-06-19
RS50341B (sr) 2009-11-10
KR100702540B1 (ko) 2007-04-04
HK1049628A1 (en) 2003-05-23
ES2226914T3 (es) 2005-04-01
CZ2002630A3 (cs) 2002-09-11
MEP9108A (en) 2010-06-10
PL353481A1 (en) 2003-11-17
PT1214052E (pt) 2004-12-31
IL148438A (en) 2006-12-10
BR0013754A (pt) 2002-05-21
US20090062362A1 (en) 2009-03-05
US9040571B2 (en) 2015-05-26
SK285825B6 (sk) 2007-09-06
EP1214052B1 (en) 2004-08-11
EA004785B1 (ru) 2004-08-26
BG106448A (en) 2002-09-30
ATE273000T1 (de) 2004-08-15
AU7322900A (en) 2001-04-10
HU229311B1 (en) 2013-10-28
IL148438A0 (en) 2002-09-12
MY128072A (en) 2007-01-31
EE05052B1 (et) 2008-08-15
UA72933C2 (uk) 2005-05-16
JP2003508482A (ja) 2003-03-04
HUP0202686A2 (hu) 2004-05-28
AR025470A1 (es) 2002-11-27
HK1049628B (zh) 2005-05-13
HUP0202686A3 (en) 2004-06-28
MXPA02002360A (es) 2002-07-30
ME00132B (me) 2010-10-10
CA2383164C (en) 2008-07-08
PL201484B1 (pl) 2009-04-30
WO2001017504A1 (en) 2001-03-15
AU775216B2 (en) 2004-07-22
CA2383164A1 (en) 2001-03-15
KR20020063844A (ko) 2002-08-05
JP4754139B2 (ja) 2011-08-24
YU14302A (sh) 2004-11-25
TWI234468B (en) 2005-06-21
SI1214052T1 (en) 2005-02-28
SK2642002A3 (en) 2002-12-03
DE60012947T2 (de) 2005-08-25
EE200200094A (et) 2003-04-15
HRP20020173B1 (en) 2005-02-28
BG65673B1 (bg) 2009-06-30
TR200200532T2 (tr) 2002-07-22

Similar Documents

Publication Publication Date Title
ZA200201708B (en) Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system.
DE60013445D1 (de) Pharmazeutische dosierungsformen zur kontrollierter pulsierender abgabe
DZ2371A1 (fr) Formulations pharmaceutiques pour la distribution prolongée de médicaments.
IL140761A0 (en) Sustained release pharmaceutical preparation
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
ES2172239T3 (es) Sistema osmotico de liberacion de farmacos.
EP1091732A4 (en) ORAL EFFERVESCENT MEDICATION DELIVERY SYSTEM
HUP0200895A3 (en) Benzimidazole derivatives of alpha-substituted carboxylic acids, pharmaceutical compositions containing them and their use
DE60020501D1 (de) Trimetazidinhaltige Matrixtablette zur verlängerten Wirkstofffreisetzung nach oraler Gabe
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
FR2793688B1 (fr) Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
EP1047435A4 (en) USE OF AN AQUEOUS SOLUTION IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF LIVE ANIMALS
ZA981354B (en) Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water
AU1581795A (en) Lure for facilitating the administration of drugs to certain animals, particularly dogs
DK1214052T3 (da) Veterinærformulering til indgivelse af et vanduoplöseligt lægemiddel til et måldyr via et vandfordelingssystem
CA2348841A1 (en) Improved growth stimulant compositions
FR2799977B1 (fr) Systeme d'injection de produits pharmaceutiques pourvu de moyens de neutralisation de l'aiguille apres utilisation
CO4910116A1 (es) Formulacion de liberacion controlada para farmacos basicos escasamente solubles
FR2796807B1 (fr) Systeme de distribution controlee d'un aliment liquide a un groupe d'animaux
AU2917800A (en) Cannula for artificial insemination of hogs
GT199700078A (es) Formulacion de liberacion controlada para farmacos basicos escasamente solubles
IL149853A0 (en) Gastroretentive controlled release pharmaceutical dosage forms
SI0973505T1 (en) Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water
GB9805623D0 (en) System for delivering a beneficial substance to an animal